Evidence map›Paper›PMID 28655873›Full record

ArticleScientific reports2017

Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Sabine François, Véronique Eder, Karim Belmokhtar, Marie-Christine Machet, Luc Douay, Norbert-Claude Gorin, Marc Benderitter, Alain Chapel

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Effects of bone morphogenetic proteins on epithelial repair.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sabine FrançoisLaboratory of Research on Irradiated Healthy Tissue Regeneration (LR2I), Institute for Radiological Protection and Nuclear Safety (IRSN), F-92260, Fontenay-aux-Roses, France.
Véronique EderLaboratory of Research on Irradiated Healthy Tissue Regeneration (LR2I), Institute for Radiological Protection and Nuclear Safety (IRSN), F-92260, Fontenay-aux-Roses, France.
Karim BelmokhtarLAB.P.ART.-EA3852 Faculty of Medicine, University of Tours, 2 bis boulevard Tonnellé, 37000, Tours, France.
Marie-Christine MachetLAB.P.ART.-EA3852 Faculty of Medicine, University of Tours, 2 bis boulevard Tonnellé, 37000, Tours, France.
Luc DouayProliferation and Differentiation of Stem Cells, Centre de Recherche Saint-Antoine (CRSA), UMR_S938, Faculté de médecine Pierre et Marie Curie, France Institut National de la Santé et de la Recherche Médicale (INSERM) U938, 27 rue de Chaligny, 75012, Paris, Paris, France.
Norbert-Claude GorinProliferation and Differentiation of Stem Cells, Centre de Recherche Saint-Antoine (CRSA), UMR_S938, Faculté de médecine Pierre et Marie Curie, France Institut National de la Santé et de la Recherche Médicale (INSERM) U938, 27 rue de Chaligny, 75012, Paris, Paris, France.
Marc BenderitterLaboratory of Research on Irradiated Healthy Tissue Regeneration (LR2I), Institute for Radiological Protection and Nuclear Safety (IRSN), F-92260, Fontenay-aux-Roses, France.
Alain ChapelLaboratory of Research on Irradiated Healthy Tissue Regeneration (LR2I), Institute for Radiological Protection and Nuclear Safety (IRSN), F-92260, Fontenay-aux-Roses, France. alain.chapel@irsn.fr.ORCID 0000-0002-4687-4120
Institut de Radioprotection et de Sûreté Nucléaire · FRUniversité de Tours · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic skin ulcers and burns require advanced treatments. Mesenchymal Stromal Cells (MSCs) are effective in treating these pathologies. Bone Morphogenic Protein-2 (BMP-2) is known to enhance angiogenesis. We investigated whether recombinant human hBMP-2 potentiates the effect of MSCs on wound healing. Severe ulceration was induced in rats by irradiation and treated by co-infusion of MSCs with hBMP-2 into the ulcerated area which accelerated wound healing. Potentiation of the effect of MSCs by hBMP-2 on endothelial repair improved skin healing. HBMP-2 and MSCs synergistically, in a supra additive or enhanced manner, renewed tissue structures, resulting in normalization of the epidermis, hair follicles, sebaceous glands, collagen fibre density, and blood vessels. Co-localization of MSCs with CD31 + cells suggests recruitment of endothelial cells at the site of injection. HBMP-2 and MSCs enhanced angiogenesis and induced micro-vessel formation in the dermis where hair follicles were regenerated. HBMP-2 acts by causing hypoxia-inducible factor-1 α (HIF-1α) expression which impacts endothelial tube formation and skin repair. This effect is abolished by siRNA. These results propose that new strategies adding cytokines to MSCs should be evaluated for treating radiation-induced dermatitis, burns, and chronic ulcers in humans.

Identifiers

PMID28655873
PMCPMC5487365
OpenAlexW2690976564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.